In one paragraphArticle in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 84% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 2 institutions in 1 country.
Martin FayolleCIRI, Centre International de Recherche en Infectiologie, GIMAP Team, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, 69007 Lyon, France.ORCID 0000-0001-7778-6222 Amélie EpercieuxFaculty of Medicine, Jean Monnet St-Etienne University, 42023 St-Etienne, France.
Cyrille H HaddarFaculty of Medicine, Jean Monnet St-Etienne University, 42023 St-Etienne, France.
Sylvie PilletCIRI, Centre International de Recherche en Infectiologie, GIMAP Team, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, 69007 Lyon, France.ORCID 0000-0002-0882-3162 Philippe BerthelotCIRI, Centre International de Recherche en Infectiologie, GIMAP Team, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, 69007 Lyon, France.ORCID 0000-0001-9356-8081 Bruno PozzettoCIRI, Centre International de Recherche en Infectiologie, GIMAP Team, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, 69007 Lyon, France.ORCID 0000-0002-2603-8467 Anne CarricajoCIRI, Centre International de Recherche en Infectiologie, GIMAP Team, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, 69007 Lyon, France.
Florence GrattardCIRI, Centre International de Recherche en Infectiologie, GIMAP Team, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, 69007 Lyon, France.
Paul O VerhoevenCIRI, Centre International de Recherche en Infectiologie, GIMAP Team, Inserm, U1111, CNRS, UMR5308, ENS Lyon, Claude Bernard Lyon 1 University, 69007 Lyon, France.ORCID 0000-0003-4352-1263 Université Claude Bernard Lyon 1 · FRUniversité Jean Monnet · FR
Funding
Becton Dickinson (France) 1208034
6 · The paper itselfAbstract
Indexed as
Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsHumansIntensive Care UnitsMethicillinProspective StudiesSensitivity and SpecificityStaphylococcus aureusMethicillinBD MAX StaphSRmethicillin resistancemolecular techniquesMRSAnasal carriernasal swabStaphylococcus aureus
Identifiers
PMID37762183
PMCPMC10531305
OpenAlexW4386614789
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390